9 completed, 2 active not recruiting, 1 recruiting, 1 terminated. 14 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 14 | Completed 9, Active not recruiting 2, Recruiting 1, Terminated 1, Unknown 1 |
Follow Relapsing Remitting Multiple Sclerosis: new trials by email Literature Review of Relapsing Remitting Multiple Sclerosis trials Research Report on Relapsing Remitting Multiple Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study Implant Procedure, Disease-Modifying Therapies (DMTs), Active stimulation - Relapsing Remitting Multiple Sclerosis | Not applicable | Recruiting | SetPoint Medical Corporation | 60 | 2026-04-17 | 2026-09-02 |
| Comparative Study of High-Efficacy Disease Modifying Treatment of Relapsing Multiple Sclerosis Blood samples - Relapsing Remitting Multiple Sclerosis | Not applicable | Unknown | University of Aarhus | 200 | 2023-11-27 | 2023-12-07 |
| Functional Outcomes From Diets in Multiple Sclerosis Glycemic load, Calorie restriction, Behavioral support - Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis | Not applicable | Active not recruiting | University of Alabama at Birmingham | 100 | 2023-03-20 | 2026-04-03 |
| Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS) Adaptive Optics Ophthalmoscopy (AOO) - Relapsing Remitting Multiple Sclerosis, Progressive Multiple Sclerosis | Not applicable | Completed | Institut National de la Santé Et de la Recherche Médicale, France | 50 | 2020-12-01 | 2026-04-27 |
| Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis Therapeutic diet and lifestyle - Clinically Isolated Syndrome, Relapsing Remitting Multiple Sclerosis | Not applicable | Active not recruiting | Terry L. Wahls | 44 | 2020-05-01 | 2025-12-26 |
| Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis Blood withdrawal, MRI, Neurologic / neuropsychologic tests - Patients - Relapsing Remitting Multiple Sclerosis, Progressive Multiple Sclerosis | Not applicable | Completed | University Hospital, Montpellier | 58 | 2019-12-09 | 2025-09-30 |
| Intermittent Fasting in Multiple Sclerosis Intermittent fasting - Relapsing Remitting Multiple Sclerosis | Not applicable | Completed | Washington University School of Medicine | 61 | 2018-01-01 | 2024-01-16 |
| Neuropsychological Management of Multiple Sclerosis: Benefits of a Computerised Semi-autonomous At-home Cognitive Rehabilitation Programme Cognitive rehabilitation, Standard Psychological care - Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis | Not applicable | Completed | University Hospital, Caen | 40 | 2017-10-31 | 2025-07-25 |
| Behavior Cognitive Therapy on Fatigue Impact in MS Patients Behavorial Cognitive Therapy (BCT) - Relapsing Remitting Multiple Sclerosis, Fatigue | Not applicable | Completed | Réseau Sep Idf Ouest | 105 | 2017-05-31 | 2021-03-16 |
| A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis Diet - Relapsing Remitting Multiple Sclerosis | Not applicable | Completed | Johns Hopkins University | 36 | 2015-12-01 | 2017-11-17 |
| High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis Patients Vitamin D3 - Relapsing Remitting Multiple Sclerosis | Not applicable | Completed | Isfahan University of Medical Sciences | 200 | 2015-07-01 | 2016-03-02 |
| Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis tDCS - Relapsing Remitting Multiple Sclerosis, Secondary-progressive Multiple Sclerosis | Not applicable | Terminated | University Hospital of Mont-Godinne | 100 | 2014-10-01 | 2023-05-09 |
| Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS) Acthar - Relapsing Remitting Multiple Sclerosis | Not applicable | Completed | OhioHealth | 30 | 2014-06-01 | 2020-09-01 |
| Eszopiclone for Improving Sleep in Multiple Sclerosis (MS) eszopiclone, placebo - Relapsing Remitting Multiple Sclerosis, Sleep Initiation and Maintenance Disorders | Not applicable | Completed | University of Vermont | 30 | 2006-12-01 | 2009-01-05 |
Multiple Sclerosis, Relapsing-Remitting (14) · Multiple Sclerosis (5) · Multiple Sclerosis, Chronic Progressive (5) · Fatigue (3) · Nervous System Diseases (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Eye Diseases (1) · Intermittent Fasting (1) · Neurologic Manifestations (1) · Optic Nerve Diseases (1) · Optic Neuritis (1) · Peripheral Nervous System Diseases (1) · Sleep Initiation and Maintenance Disorders (1)
Autoimmune Diseases (14) · Autoimmune Diseases of the Nervous System (14) · Demyelinating Autoimmune Diseases, CNS (14) · Demyelinating Diseases (14) · Immune System Diseases (14) · Nervous System Diseases (12) · Multiple Sclerosis (9) · Pathological Conditions, Signs and Symptoms (7) · Chronic Disease (5) · Disease Attributes (5) · Pathologic Processes (5) · Signs and Symptoms (3) · Mental Disorders (2) · Behavior (1) · Cranial Nerve Diseases (1)
Adrenocorticotropic Hormone (1) · Behavior Therapy (1) · Blood Specimen Collection (1) · Caloric Restriction (1) · Cholecalciferol (1) · Cognitive Training (1) · Diet (1) · Drug Implants (1) · Eszopiclone (1) · Glycemic Load (1) · Transcranial Direct Current Stimulation (1)
Institut National de la Santé Et de la Recherche Médicale, France (1) · Isfahan University of Medical Sciences (1) · Johns Hopkins University (1) · OhioHealth (1) · Réseau Sep Idf Ouest (1) · SetPoint Medical Corporation (1) · Terry L. Wahls (1) · University Hospital of Mont-Godinne (1) · University Hospital, Caen (1) · University Hospital, Montpellier (1) · University of Aarhus (1) · University of Alabama at Birmingham (1) · University of Vermont (1) · Washington University School of Medicine (1)
United States (7) · France (4) · Belgium (1) · Denmark (1) · Iran (1)
Aaron L Boster, MD (1) · Brooks Wingo, PhD (1) · Celine Louapre, MD, PHD (1) · Ellen Mowry, MD (1) · Gilles Defer, Pr (1) · Hrayr Attarian, MD (1) · Masoud Etemadifar, professor (1) · Morten Stilund, MD (1) · Terry L Wahls, MD (1)
PMID 10773854, PMID 11074395, PMID 11594918, PMID 11955556, PMID 12051465, PMID 12785670, PMID 12814166, PMID 14967763, PMID 15824337, PMID 16193899, PMID 17409388, PMID 18201113, PMID 18256342, PMID 18344396, PMID 19361678, PMID 20070277, PMID 20166093, PMID 21672300, PMID 23459569, PMID 23497281, PMID 23695501, PMID 25112509, PMID 2630556, PMID 37648439, PMID 38222092, PMID 38821260, PMID 39137977, PMID 39464680, PMID 41788164, PMID 8621999, PMID 866038, PMID 9827769